GlassScriptPhysician profile
Karlos Pena
NPI 1366020687
$4,819.99
in general payments reported to CMS, 2019-2025
11 companies · $1,899 in 2025
The $1,899 reported for 2025 was more than what 82% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $80.78 · 2024: $2,840 · 2025: $1,899.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,400 · Travel and Lodging: $1,220 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,399.92 |
| Travel and Lodging | $1,220.08 |
| Education | $199.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,692.21 | 2024-2025 | Infinity, Inbone, Graftjacket |
| Integra Lifesciences Corporation | $991.90 | 2024-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Fusion Orthopedics USA, LLC | $230.62 | 2025 | |
| Medical Device Business Services, INC. | $199.99 | 2024 | |
| Biocomposites INC | $152.77 | 2025 | Stimulan |
| Orthofix Medical, INC. | $147.44 | 2025 | Truelok |
| Treace Medical Concepts, INC. | $140.74 | 2024 | |
| Abbott Laboratories | $132.55 | 2025 | Esprit |
| Seapearl East, INC | $95.76 | 2023-2024 | |
| Mimedx Group, INC. | $19.83 | 2025 | |
| Paratek Pharmaceuticals, INC. | $16.18 | 2025 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karlos Pena listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.